Swiss perspectives in 10 languages

Top Swiss firms pay respects to ‘formative’ business leader Fritz Gerber

Fritz Gerber
Fritz Gerber worked for the Basel-based pharma giant for more than two decades, shaping Roche's development into a global healthcare firm. Keystone / Markus Stuecklin

Pharmaceutical giant Roche and Zurich Insurance have paid their respects to business executive Fritz Gerber, who passed away on Sunday at the age of 91. 

“Fritz Gerber was one of the most influential business leaders in Switzerland during a period of formative development for the country’s modern, open economy,” Zurich Insurance said in a statementExternal link on Monday.

Born on March 22, 1929, in Huttwil, canton Bern, Gerber worked for the insurance firm for almost 40 years, including 17 years as chief executive officer and 18 years as chairman of the board of directors. 

“At Zurich, his leadership was characterized by a far-sightedness, a strategic mindset and an ability to bring out the best in people. He significantly contributed to Zurich’s strategic positioning and commercial success,” said Zurich Chairman Michel M. Liès.

Roche also describedExternal link Gerber as a “formative figure”. He worked for the Basel-based pharma giant for more than two decades shaping Roche’s development into a leading global healthcare company. He was Group CEO (1978-1998) and chairman of the board (1978-2001) and remained closely associated with the company as honorary chairman.

“Under his leadership, Roche’s Group structures were fundamentally renewed and decentralized– ranging from focusing on the core businesses to modernizing the capital structure. This created a fundamental change at Roche that still encourages entrepreneurial thinking today, and empowers employees to make their mark,” the firm said in a statement.

During his time at Roche, Gerber was behind biotechnology acquisitions such as the majority shareholding in Genentech at the beginning of the 1990s. He also led the takeover of Boehringer Mannheim, which ensured that Roche has become one of the world’s leading molecular and laboratory diagnostics groups.

More
Roche tower

More

Inside Roche: Taking on the tech sector

This content was published on With its big bet on data and digitilisation, Roche has its eye on a new crop of specialists. Now it just needs to woo them.

Read more: Inside Roche: Taking on the tech sector

Popular Stories

Most Discussed

News

In compliance with the JTI standards

More: SWI swissinfo.ch certified by the Journalism Trust Initiative

You can find an overview of ongoing debates with our journalists here . Please join us!

If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.

SWI swissinfo.ch - a branch of Swiss Broadcasting Corporation SRG SSR

SWI swissinfo.ch - a branch of Swiss Broadcasting Corporation SRG SSR